Investing.com - Allergan (NYSE:AGN) reported fourth quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $4.29 on revenue of $4.08B. Analysts polled by Investing.com anticipated EPS of $4.16 on revenue of $3.99B. That compared to EPS of $4.86 on revenue of $4.33B in the same period a year earlier. The company had reported EPS of $4.25 on revenue of $3.91B in the previous quarter.
For the year, Allergan shares are up 18.73%, outperforming the S&P 500 which is up 7.14% year to date.
Allergan follows other major Healthcare sector earnings this month
On Tuesday, January 22, 2019, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings matched analyst's expectations on Tuesday, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.64 on revenue of $13.96B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar